MRI brain scans of Prader-Willi syndrome (PWS) patients unexpectedly revealed nerve cells in the cerebellum of the brain activated…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
In a “significant subset” of  children with Prader-Willi syndrome (PWS), obstructive sleep apnea worsened after the start of growth…
An $11.2-million, five-year grant has been awarded by the Centers of Excellence in Genomic Science of the National Institutes of…
The hunger hormone ghrelin, when measured in infancy, may be a biomarker for predicting the early onset of scoliosis…
Radius Health plans to initiate a Phase 2/3 study to evaluate the safety and efficacy of its investigational therapy…
Transcranial direct current stimulation (tDCS) — a non-invasive brain stimulation technique — altered brainwave patterns in…
Growth hormone therapy should be universally available, given to adults as well as children with…
Due to the COVID-19 pandemic, the Prader-Willi Syndrome Association (PWSA) in the U.S.
Intranasal use of the hormone oxytocin for three months had positive effects on social and…
Starting growth hormone therapy before the first birthday has significant benefits…